Cerus Corporation

CERS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.

2.20 0.06 −2.65%
Market cap
$455.5M
P/E
0.0×
Fwd P/E
−81.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
5 5 4 4 3 5 3 5 4 4
P/S ratio
1.68 1.41 2.08 3.51 7.31 9.93 6.29 8.78 7.51 11.23
Altman Z-Score
(4.00) (4.94) (4.87) (3.24) (0.54) 0.35 (4.12) (1.55) (7.17) (3.92)
P/FCF ratio
354.35 33.35 0.00 52.87 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(13.54) (14.46) (15.30) (14.03) (11.03) (10.58) (15.80) (12.89) (22.72) (19.22)
Beneish M-Score
(2.87) (3.35) (2.22) (2.52) (2.51) (2.66) (1.34) (3.05) (2.44) (2.82)
P/Operating CF
63.33 57.66 (25.65) (376.01) (954.51) (127.46) (71.77) (94.08) (38.39) (45.40)
P/B ratio
6.04 5.00 7.29 9.63 13.62 10.93 10.34 7.90 9.89 7.63
Price to Tangible BV
6.17 5.11 7.47 9.82 13.84 11.07 10.61 8.06 10.39 7.91
EV/Sales
1.68 1.43 2.16 3.33 6.94 9.18 5.85 7.62 7.01 9.90
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
81.38 25.35 (9.34) (24.51) (32.62) (25.09) (8.38) (18.56) (6.89) (7.26)
EV/FCF
355.26 33.79 (8.44) 50.28 (31.77) (24.16) (7.37) (17.90) (6.84) (7.18)
Quick Ratio
1.12 1.73 1.50 1.17 1.97 2.58 2.04 2.40 3.16 2.92
Current Ratio
1.73 2.39 2.14 1.45 2.38 3.06 2.55 2.79 3.89 3.50
Net Debt/EBITDA
(0.14) (0.30) (0.51) 1.04 1.31 1.55 0.65 1.64 0.55 0.88
Debt/Assets
37.81% 41.89% 40.35% 32.01% 29.23% 21.73% 26.84% 18.27% 30.33% 18.72%
Debt/Equity
1.29 1.48 1.49 1.02 0.81 0.46 0.78 0.35 0.77 0.34
Asset Turnover
1.11 1.01 0.90 0.83 0.70 0.59 0.57 0.58 0.51 0.32
Operating CF/Net income
(0.31) (0.54) 1.15 0.60 0.62 0.70 0.92 0.54 0.86 0.85
Capex/Depreciation
(2.61) (1.53) (1.77) 12.77 (0.29) (0.52) (3.72) (0.79) (0.19) (0.31)
Interest Coverage
(1.04) (1.60) (3.58) (5.84) (9.94) (15.57) (10.92) (13.72) (19.04) (25.13)
ROE
(25.65%) (37.92%) (61.45%) (55.49%) (57.41%) (74.42%) (100.65%) (93.25%) (125.27%) (82.47%)
ROA
(7.39%) (10.49%) (18.03%) (18.78%) (23.70%) (30.94%) (43.31%) (43.99%) (60.07%) (51.80%)
ROIC
(8.22%) (14.67%) (27.87%) (58.82%) (119.11%) (199.05%) (262.55%) 0.00% (447.11%) (693.97%)
Return on Tangible Assets
(18.88%) (21.89%) (43.82%) (66.78%) (45.03%) (43.59%) (76.88%) (56.24%) (87.95%) (89.61%)
Average Days of Receivables
47.42 53.99 69.37 66.73 57.50 67.62 65.71 42.00 88.29 63.83
Research and Development Expense of Revenue
28.97% 29.26% 36.21% 34.04% 39.93% 56.38% 64.38% 55.97% 65.68% 79.75%
Selling, General and Administrative Expense of Revenue
34.61% 37.70% 40.43% 44.25% 50.96% 58.66% 70.60% 74.74% 102.51% 124.65%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02
Share Based Compensation of Revenue
9.78% 11.36% 10.85% 12.99% 14.78% 15.78% 14.20% 13.67% 18.23% 20.53%
Graham Net Nets
0.04 0.03 0.00 0.03 0.03 0.06 0.03 0.10 0.08 0.11
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(3.89%) (7.08%) (9.58%) (6.68%) (4.55%) (5.20%) (12.32%) (8.68%) (15.73%) (14.32%)
Free Cash Flow Yield
0.28% 3.00% (12.27%) 1.89% (2.99%) (3.83%) (12.61%) (4.85%) (13.65%) (12.27%)
Revenue per Share
1.23 1.09 1.04 1.07 0.93 0.70 0.67 0.58 0.47 0.39
Operating CF per Share
0.03 0.06 (0.24) (0.15) (0.20) (0.25) (0.47) (0.24) (0.48) (0.53)
Capex per Share
(0.02) (0.02) (0.03) 0.22 (0.01) (0.01) (0.06) (0.01) 0.00 (0.01)
Free Cash Flow per Share
0.01 0.05 (0.26) 0.07 (0.20) (0.26) (0.53) (0.25) (0.49) (0.53)
Cash per Share
0.43 0.44 0.37 0.58 0.76 0.81 0.61 0.89 0.56 0.70
Shareholders Equity per Share
0.34 0.31 0.30 0.39 0.50 0.63 0.41 0.64 0.36 0.57
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.34 0.31 0.30 0.39 0.50 0.63 0.41 0.64 0.36 0.57
Free Cash Flow
1.11 8.52 (47.76) 12.49 (34.83) (43.43) (74.43) (32.39) (52.59) (54.09)
Working Capital
73.58 88.41 76.92 53.09 108.55 123.46 77.77 94.22 66.77 67.22
Capital Expenditures
(3.73) (2.84) (4.60) 38.10 (0.91) (1.61) (8.93) (1.14) (0.35) (0.56)
Net Current Asset Value
17.49 8.00 0.14 20.61 35.22 65.82 19.63 67.96 30.59 48.42
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.01 0.02 (0.20) 0.01 0.01 0.10 0.02 0.01 0.01
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.15 0.26 0.30 0.27 0.26 0.22 0.16 0.18 0.85 0.61
Cash ROIC
0.48% 3.85% (23.99%) 5.19% (12.25%) (15.21%) (39.76%) (13.96%) (40.63%) (36.35%)
Accounts Receivable Turnover
7.77 6.17 5.34 6.32 6.89 6.01 7.32 7.19 5.32 6.20
Accounts Payable Turnover
3.78 3.55 2.46 2.18 2.12 1.77 1.64 2.14 2.30 2.94
Inventory Turnover
1.99 2.07 2.03 2.69 2.54 1.93 2.02 2.26 1.67 1.74
Average Days of Payables
108.93 98.07 124.38 160.71 204.76 214.73 242.30 214.55 177.78 154.43
Days of Inventory on Hand
218.20 172.45 207.98 141.23 154.07 206.23 212.87 156.22 234.20 225.37
Average Receivables
30.08 32.64 34.96 29.78 23.15 19.02 12.82 10.58 9.64 6.33
Average Payables
24.85 22.77 28.42 34.31 29.91 23.20 20.39 14.78 9.78 6.90
Average Inventory
47.13 39.01 34.44 27.90 25.02 21.37 16.51 14.00 13.49 11.67
Average Assets
211.39 199.33 207.92 227.80 229.46 193.48 164.50 130.85 100.86 121.44
Average Common Equity
60.93 55.17 61.00 77.09 94.71 80.43 70.79 61.73 48.36 76.28

Fold the line items

Columns are period end dates